Huang et al. found that high expression of miR-29 could regulate the STAT3 signaling pathway to inhibit the proliferation, invasion, and metastasis of uterine leiomyoma in vitro; thus, miR-29 might be a new target for treating uterine leiomyoma [80]. The gene discussed is STAT3; the disease is uterine corpus leiomyoma.